Prothena has initiated Phase 1 SAD study of PRX012, under investigation for the treatment of Alzheimer's disease DUBLIN, Ireland, March 28, 2022 (GLOBE NEWSWIRE) Prothena Corporation plc (NASDAQ:PRTA)
Prothena Corp (PRTA) Presents Data for Alzheimer s and Parkinson s Disease Programs streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights •Net cash used in operating. | February 17, 2022
Net cash used in operating and investing activities was $22.8 million in the fourth quarter and net cash provided by operating and investing activities was $92.0 million for the full year 2021; quarter-end
Investegate announcements from Prothena Corporation plc, Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights